TY - JOUR
T1 - Benzodiazepine and sedative use/abuse by methadone maintenance clients
AU - Iguchi, Martin Y.
AU - Handelsman, Leonard
AU - Bickel, Warren K.
AU - Griffiths, Roland R.
N1 - Funding Information:
This researchw as supportedi n part by NIDA research grants ROl DA03889, R18 DA06096, and training grant T32 DA07209. The authors also wish to acknowledge ti A. Thomas McLellan and Dr Anna Rose Childress for their assistance in collecting the data at the Philadelphias ite, and Dr Joyce H. Lowinson and Dr John G. Langrod for their assistancei n collecting the data at the New York City (The Bronx) site.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1993/5
Y1 - 1993/5
N2 - Clients at three geographically separate methadone maintenance clinics were surveyed regarding their lifetime use of ten commonly used benzodiazepines and barbiturates. In Baltimore (n = 50), 94% reported use of one or more of these drugs in their lifetime, with 66% reporting use in the last 6 months. In Philadelphia (n = 218), 78% reported use in their lifetime, with 53% reporting use in the last 6 months. In New York City (The Bronx) (n = 279), 86% reported use in their lifetime, with 44% reporting use in the last 6 months. Subjects reporting a history of use of at least 7 of 10 of the named sedatives were recruited for a more detailed interview. They reported that, among the benzodiazepines, diazepam, lorazepam, and alprazolam were frequently used for their 'high' producing effects, and for selling to produce income. In contrast, chlordiazepoxide, oxazepam, and phenobarbital, had much lower ratings of 'high' and were much less likely to be obtained for getting 'high' or for resale.
AB - Clients at three geographically separate methadone maintenance clinics were surveyed regarding their lifetime use of ten commonly used benzodiazepines and barbiturates. In Baltimore (n = 50), 94% reported use of one or more of these drugs in their lifetime, with 66% reporting use in the last 6 months. In Philadelphia (n = 218), 78% reported use in their lifetime, with 53% reporting use in the last 6 months. In New York City (The Bronx) (n = 279), 86% reported use in their lifetime, with 44% reporting use in the last 6 months. Subjects reporting a history of use of at least 7 of 10 of the named sedatives were recruited for a more detailed interview. They reported that, among the benzodiazepines, diazepam, lorazepam, and alprazolam were frequently used for their 'high' producing effects, and for selling to produce income. In contrast, chlordiazepoxide, oxazepam, and phenobarbital, had much lower ratings of 'high' and were much less likely to be obtained for getting 'high' or for resale.
KW - alprazolam
KW - barbiturates
KW - benzodiazepines
KW - diazepam
KW - drug abuse
KW - lorazepam
KW - methadone maintenance
KW - sedatives
UR - http://www.scopus.com/inward/record.url?scp=0027182707&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027182707&partnerID=8YFLogxK
U2 - 10.1016/0376-8716(93)90090-D
DO - 10.1016/0376-8716(93)90090-D
M3 - Article
C2 - 8102331
AN - SCOPUS:0027182707
SN - 0376-8716
VL - 32
SP - 257
EP - 266
JO - Drug and Alcohol Dependence
JF - Drug and Alcohol Dependence
IS - 3
ER -